1. Homepage
  2. Equities
  3. Taiwan
  4. Taiwan Stock Exchange
  5. Tatung Co., Ltd.
  6. News
  7. Summary
    2371   TW0002371002

TATUNG CO., LTD.

(2371)
  Report
End-of-day quote Taiwan Stock Exchange  -  2022-06-28
34.40 TWD   +0.88%
10:09aTATUNG : Announced by Tatung Co. on behalf of Shan-Chih Asset Development Co. (Proxy executive shareholder meeting) board of Directors' resolved no dividend
PU
10:09aTATUNG : Announced by Tatung Company on behalf of Shan-Chih Asset Development Co. approving for obtaining real estate(Supplementary announcement of 2021/12/22)
PU
10:09aTATUNG : Announce the new Chairperson by Tatung Co. on behalf of subsidiary SCAD
PU
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Tatung : Announced by Tatung Company on behalf of Tatung Medical & Healthcare Technologies Co.,Ltd.,for disposal (Termination of the lease)the right-of-use asset to SCAD

04/29/2022 | 03:13am EDT
Close
Today's Information

Provided by: TATUNG CO.
SEQ_NO 1 Date of announcement 2022/04/29 Time of announcement 15:01:17
Subject
 Announced by Tatung Company on behalf of Tatung
Medical & Healthcare Technologies Co.,Ltd.,for disposal
(Termination of the lease)the right-of-use asset to SCAD
Date of events 2022/04/29 To which item it meets paragraph 20
Statement
1.Name and nature of the underlying asset (e.g., land located at Sublot XX,
Lot XX, North District, Taichung City):
No. 136, Sec. 3, Ren'ai Rd., Da'an Dist., Taipei City 106, Taiwan (R.O.C.)
(1 underground parking space)
2.Date of occurrence of the event:2022/04/29
3.Transaction unit amount (e.g.XX square meters, equivalent to XX ping),
unit price, and total transaction price:
The lease is going to terminate at the end of April.
Decrease amount of monthly payment:NT$8,000
Decrease amount of right-of-use assets:NT$62,048
Decrease amount of lease liabilities:NT$63,286
4.Trading counterparty and its relationship with the Company (if the trading
counterparty is a natural person and furthermore is not a related party of
the Company, the name of the trading counterparty is not required to be
disclosed):
Shan-Chih Asset Development Co.
TATUNG MEDICAL & HEALTHCARE TECHNOLOGIES CO., LTD. and Shan-Chih Asset
Development Co. both are Tatung company's subsidiaries.
5.Where the trading counterparty is a related party, announcement shall also
be made of the reason for choosing the related party as trading counterparty
and the identity of the previous owner, its relationship with the Company
and the trading counterparty, and the previous date and monetary amount of
transfer:
(1)The reason for choosing the related party as trading counterpart:
   Apply to the original landlord.
(2)The owner of the previous transfer:N/A
(3)Relationship between the owner of the previous transfer and the company
  and the relative of the transaction :N/A
(4)Previous transfer date and transfer amount: N/A
6.Where an owner of the underlying assets within the past five years has
been a related party of the Company, the announcement shall also include the
date and price of acquisition and disposal by the related party, and its
relationship with the Company at the time of the transaction:NA
7.Projected gain (or loss) through disposal (not applicable for
acquisition of assets; those with deferral should provide a table
explaining recognition):Projected gain NT$1,238
8.Terms of delivery or payment (including payment period and
monetary amount), restrictive covenants in the contract,
and other important terms and conditions:
The lease is going to terminate at the end of April.
(Original payment period: 2022/1/1~2022/12/31)
9.The manner of deciding on this transaction (such as invitation to tender,
price comparison, or price negotiation), the reference basis for the
decision on price, and the decision-making unit:N/A
10.Name of the professional appraisal firm or company and
its appraisal price:N/A
11.Name of the professional appraiser:N/A
12.Practice certificate number of the professional appraiser:N/A
13.The appraisal report has a limited price, specific price,
or special price:N/A
14.An appraisal report has not yet been obtained:N/A
15.Reason for an appraisal report not being obtained:N/A
16.Reason for any significant discrepancy with the appraisal reports
and opinion of the CPA:N/A
17.Name of the CPA firm:N/A
18.Name of the CPA:N/A
19.Practice certificate number of the CPA:N/A
20.Broker and broker's fee:N/A
21.Concrete purpose or use of the acquisition or disposal:
Cooperate with company operations.
22.Any dissenting opinions of directors to the present transaction:
N/A
23.Whether the counterparty of the current transaction is a
related party:Yes
24.Date of the board of directors resolution:
TATUNG MEDICAL & HEALTHCARE TECHNOLOGIES CO., LTD. , the date of
the board of directors resolution : 2022/04/29
25.Date of ratification by supervisors or approval by
the audit committee:2022/04/29
26.The transaction is to acquire a real property or right-of-use
asset from a related party:N/A
27.The price assessed in accordance with the Article 16 of the
Regulations Governing the Acquisition and Disposal of Assets
by Public Companies:N/A
28.Where the above assessed price is lower than the transaction price,
the price assessed in accordance with the Article 17 of the same
regulations:N/A
29.Any other matters that need to be specified:N/A

Disclaimer

Tatung Company published this content on 29 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2022 07:11:01 UTC.


© Publicnow 2022
All news about TATUNG CO., LTD.
10:09aTATUNG : Announced by Tatung Co. on behalf of Shan-Chih Asset Development Co. (Proxy execu..
PU
10:09aTATUNG : Announced by Tatung Company on behalf of Shan-Chih Asset Development Co. approvin..
PU
10:09aTATUNG : Announce the new Chairperson by Tatung Co. on behalf of subsidiary SCAD
PU
05:48aTATUNG : Announcement of Director changed and the change in one-third or more of directors
PU
06/15TATUNG : Announcement of Director changed and the change in one-third or more of directors
PU
06/14TATUNG : The member of Audit Committee has changed
PU
06/14TATUNG : Announcement of the by-datton of independent director and change in one-third or ..
PU
06/14TATUNG : Announcement for the release of directors' non-competition restrictions
PU
06/14TATUNG : Announcement of Resolutions of 2022 Annual shareholder's Meeting.
PU
06/14Tatung Co., Ltd. Announces Change of Member of Audit Committee
CI
More news
Financials
Sales 2021 29 605 M 996 M 996 M
Net income 2021 3 672 M 124 M 124 M
Net Debt 2021 28 560 M 961 M 961 M
P/E ratio 2021 20,8x
Yield 2021 -
Capitalization 80 326 M 2 702 M 2 702 M
EV / Sales 2020 2,94x
EV / Sales 2021 3,54x
Nbr of Employees 3 936
Free-Float 74,6%
Chart TATUNG CO., LTD.
Duration : Period :
Tatung Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TATUNG CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Managers and Directors
Wen Chieh Peng CFO, Executive Deputy General Manager & Spokesman
Jui Kai Chang Head-Finance
Guang xiang Wang Chairman
Peng Fei Su Independent Director
Tzong Der Liou Independent Director
Sector and Competitors
1st jan.Capi. (M$)
TATUNG CO., LTD.5.52%2 679
KEYENCE CORPORATION-34.50%84 253
SCHNEIDER ELECTRIC SE-31.81%68 717
EATON CORPORATION PLC-23.48%51 599
EMERSON ELECTRIC CO.-11.27%48 415
NIDEC CORPORATION-36.21%36 575